GENNEX LABORATORIES
Back to Cashflow Statement
|
GENNEX LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹74 Cr | ₹21 Cr | ₹-1.83 Cr | ₹1.62 Cr | ₹-0.35 Cr |
What is the latest Cash Flow from Financing Activities ratio of GENNEX LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹74 Cr |
Mar2023 | ₹21 Cr |
Mar2022 | ₹-1.83 Cr |
Mar2021 | ₹1.62 Cr |
Mar2020 | ₹-0.35 Cr |
How is Cash Flow from Financing Activities of GENNEX LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹74 Cr | 250.33 | |
Mar2023 | ₹21 Cr | Positive | |
Mar2022 | ₹-1.83 Cr | Negative | |
Mar2021 | ₹1.62 Cr | Positive | |
Mar2020 | ₹-0.35 Cr | - |
Compare Cash Flow from Financing Activities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹348.1 Cr | -3.4% | -10.7% | -13.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,715.0 Cr | 0.3% | -2.6% | 36.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,460.0 Cr | -1% | -0.5% | 60.8% | Stock Analytics | |
CIPLA | ₹115,271.0 Cr | -1.4% | -3.1% | 11.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,511.0 Cr | -3.8% | -4% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,189.5 Cr | 0.1% | 1.2% | 40.3% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -3.4% |
-10.7% |
-13.1% |
SENSEX | -0.9% |
-4.3% |
3.7% |
You may also like the below Video Courses